Risk factors associated with acute exacerbation of chronic obstructive pulmonary disease in HIV-infected and uninfected patients

AIDS

Volumn 30, Issue 3, 2016, Pages 455-463

  Depp, Timothy B ^a,b   McGinnis, Kathleen A ^b   Kraemer, Kevin ^b,c   Akgun, Kathleen M ^d,e   Jennifer Edelman, E ^e   Fiellin, David A ^e   Butt, Adeel A ^b,f   Crystal, Stephen ^g   Gordon, Adam J ^b,c   Freiberg, Matthew ^h   Gibert, Cynthia L ⁱ   Rimland, David ^j   Bryant, Kendall J ^k   Crothers, Kristina ^l  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f HAMAD MEDICAL CORPORATION   (Qatar)

^g RUTGERS UNIVERSITY   (United States)

^h VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

ⁱ VETERANS AFFAIRS MEDICAL CENTER   (United States)

^j EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^l UNIVERSITY OF WASHINGTON   (United States)

more..

Author keywords

Acute exacerbation; AECOPD; AIDS HIV; Chronic obstructive pulmonary disease; Cigarette smoking; COPD; Tobacco use; Unhealthy alcohol use

Indexed keywords

ANTIBIOTIC AGENT; CD4 ANTIGEN; CEPHALOSPORIN DERIVATIVE; MACROLIDE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STEROID; SULFANILAMIDE DERIVATIVE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CD4 LYMPHOCYTE COUNT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; ADVERSE EFFECTS; ALCOHOLISM; COMPLICATION; DISEASE COURSE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

ADULT; ALCOHOLISM; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING;

EID: 84957865580     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000940     Document Type: Article

References (69)

1. Centers for Disease Control and Prevention. Chronic obstructive pulmonary disease among adults-United States, 2011. MMWR Morb Mortal Wkly Rep 2012; 61:938-943.
2. Mannino DM, Braman S. The epidemiology and economics of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2007; 4:502-506.
3. Drummond MB, Kirk GD, McCormack MC, Marshall MM, Ricketts EP, Mehta SH, et al. HIV and COPD: impact of risk behaviors and diseases on quality of life. Qual Life Res 2010; 19:1295-1302.
4. Small N, Gardiner C, Barnes S, Gott M, Halpin D, Payne S, et al. 'You get old, you get breathless, and you die': chronic obstructive pulmonary disease in Barnsley, UK. Health Place 2012; 18:1396-1403.
5. Petrache I, Diab K, Knox KS, Twigg HL 3rd, Stephens RS, Flores S, et al. HIV associated pulmonary emphysema: a review of the literature and inquiry into its mechanism. Thorax 2008; 63:463-469.
6. Oostenbrink JB, Rutten-van Molken MP. Resource use and risk factors in high-cost exacerbations of COPD. Respir Med 2004; 98:883-891.
7. Perera PN, Armstrong EP, Sherrill DL, Skrepnek GH. Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality. COPD 2012; 9:131-141.
8. Pasquale MK, Sun SX, Song F, Hartnett HJ, Stemkowski SA. Impact of exacerbations on healthcare cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population. Int J Chron Obstruct Pulmon Dis 2012; 7:757-764.
9. Mapel DW, Schum M, Lydick E, Marton JP. A new method for examining the cost savings of reducing COPD exacerbations. Pharmacoeconomics 2010; 28:733-749.
10. Sanchez CR, Cisneros GP, Penaranda CG, Ruiz C, Hernandez A, Cascales A, et al. Changes in hospitalizations due to opportunistic infections, chronic conditions and other causes among HIV patients (1989-2011). A study in a HIV unit. J Int AIDS Soc 2012; 15(Suppl 4):18089.
11. Madeddu G, Fois AG, Calia GM, Babudieri S, Soddu V, Becciu F, et al. Chronic obstructive pulmonary disease: an emerging comorbidity in HIV-infected patients in the HAART era? Infection 2012; 41:347-353.
12. Kynyk JA, Parsons JP, Para MF, Koletar SL, Diaz PT, Mastronarde JG. HIV and asthma, is there an association? Respir Med 2012; 106:493-499.
13. Kristoffersen US, Lebech AM, Mortensen J, Gerstoft J, Gutte H, Kjaer A. Changes in lung function of HIV-infected patients: a 4.5-year follow-up study. Clin Physiol Funct Imaging 2012; 32:288-295.
14. Kim DJ, Westfall AO, Chamot E, Willig AL, Mugavero MJ, Ritchie C, et al. Multimorbidity patterns in HIV-infected patients: the role of obesity in chronic disease clustering. J Acquir Immune Defic Syndr 2012; 61:600-605.
15. Gingo MR, Wenzel SE, Steele C, Kessinger CJ, Lucht L, Lawther T, et al. Asthma diagnosis and airway bronchodilator response in HIV-infected patients. J Allergy Clin Immunol 2012; 129:708-714e708.
16. Raynaud C, Roche N, Chouaid C. Interactions between HIV infection and chronic obstructive pulmonary disease: clinical and epidemiological aspects. Respir Res 2011; 12:117.
17. Morris A, George MP, Crothers K, Huang L, Lucht L, Kessinger C, et al. HIV and chronic obstructive pulmonary disease: is it worse and why? Proc Am Thorac Soc 2011; 8:320-325.
18. Crothers K, Huang L, Goulet JL, Goetz MB, Brown ST, Rodriguez-Barradas MC, et al. HIV infection and risk for incident pulmonary diseases in the combination antiretro-viral therapy era. Am J Respir Crit Care Med 2011; 183:388-395.
19. Crothers K, Thompson BW, Burkhardt K, Morris A, Flores SC, Diaz PT, et al. HIV-associated lung infections and complications in the era of combination antiretroviral therapy. Proc Am Thorac Soc 2011; 8:275-281.
20. Gingo MR, George MP, Kessinger CJ, Lucht L, Rissler B, Weinman R, et al. Pulmonary function abnormalities in HIV-infected patients during the current antiretroviral therapy era. Am J Respir Crit Care Med 2010; 182:790-796.
21. George MP, Kannass M, Huang L, Sciurba FC, Morris A. Respiratory symptoms and airway obstruction in HIV-infected subjects in the HAART era. PLoS One 2009; 4:e6328.
22. Hull MW, Phillips P, Montaner JS. Changing global epidemiology of pulmonary manifestations of HIV/AIDS. Chest 2008; 134:1287-1298.
23. Diaz PT, King MA, Pacht ER, Wewers MD, Gadek JE, Nagaraja HN, et al. Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Ann Intern Med 2000; 132:369-372.
24. Lambert AA, Kirk GD, Astemborski J, Mehta SH, Wise RA, Drummond MB. HIV infection is associated with increased risk for acute exacerbation of COPD. J Acquir Immune Defic Syndr 2015; 69:68-74.
25. Borrell E, Rodriguez M, Toran P, Munoz L, Pera G, Montella N, et al. Incidence and risk factors of exacerbations among COPD patients in primary healthcare: APMPOC study. BMC Public Health 2009; 9:8.
26. Gruffydd-Jones K. GOLD guidelines 2011: what are the implications for primary care? Prim Care Respir J 2012; 21:437-441.
27. Eisner MD, Anthonisen N, Coultas D, Kuenzli N, Perez-Padilla R, Postma D, et al. An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 182:693-718.
28. Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363:1128-1138.
29. Rosenberg SR, Kalhan R. Biomarkers in chronic obstructive pulmonary disease. Transl Res 2012; 159:228-237.
30. Messer B, Griffiths J, Baudouin SV. The prognostic variables predictive of mortality in patients with an exacerbation of COPD admitted to the ICU: an integrative review. QJM 2012; 105:115-126.
31. Matkovic Z, Huerta A, Soler N, Domingo R, Gabarrus A, Torres A, et al. Predictors of adverse outcome in patients hospitalised for exacerbation of chronic obstructive pulmonary disease. Respiration 2012; 84:17-26.
32. Martinez-Rivera C, Portillo K, Munoz-Ferrer A, Martinez-Ortiz ML, Molins E, Serra P, et al. Anemia is a mortality predictor in hospitalized patients for COPD exacerbation. COPD 2012; 9:243-250.
33. Laurin C, Moullec G, Bacon SL, Lavoie KL. Impact of anxiety and depression on chronic obstructive pulmonary disease exacerbation risk. Am J Respir Crit Care Med 2012; 185:918-923.
34. Jenkins CR, Celli B, Anderson JA, Ferguson GT, Jones PW, Vestbo J, et al. Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study. Eur Respir J 2012; 39:38-45.
35. Drummond MB, Kirk GD, Astemborski J, Marshall MM, Mehta SH, McDyer JF, et al. Association between obstructive lung disease and markers of HIV infection in a high-risk cohort. Thorax 2012; 67:309-314.
36. Donaldson GC, Goldring JJ, Wedzicha JA. Influence of season on exacerbation characteristics in patients with COPD. Chest 2012; 141:94-100.
37. Anzueto A, Sethi S, Martinez FJ. Exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2007; 4:554-564.
38. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in nonsmokers. Lancet 2009; 374:733-743.
39. Saitz R. Clinical practice. Unhealthy alcohol use. N Engl J Med 2005; 352:596-607.
40. Joshi PC, Guidot DM. The alcoholic lung: epidemiology, patho-physiology, and potential therapies. Am J Physiol Lung Cell Mol Physiol 2007; 292:L813-823.
41. Greene CC, Bradley KA, Bryson CL, Blough DK, Evans LE, Udris EM, et al. The association between alcohol consumption and risk of COPD exacerbation in a veteran population. Chest 2008; 134:761-767.
42. Lassiter C, Fan X, Joshi PC, Jacob BA, Sutliff RL, Jones DP, et al. HIV-1 transgene expression in rats causes oxidant stress and alveolar epithelial barrier dysfunction. AIDS Res Ther 2009; 6:1.
43. Happel KI, Nelson S. Alcohol, immunosuppression, and the lung. Proc Am Thorac Soc 2005; 2:428-432.
44. Sisson JH, Stoner JA, Romberger DJ, Spurzem JR, Wyatt TA, Owens-Ream J, et al. Alcohol intake is associated with altered pulmonary function. Alcohol 2005; 36:19-30.
45. Siu ST, Udaltsova N, Iribarren C, Klatsky AL. Alcohol and lung airways function. Perm J 2010; 14:11-18.
46. Moss M, Guidot DM, Wong-Lambertina M, Ten Hoor T, Perez RL, Brown LA. The effects of chronic alcohol abuse on pulmonary glutathione homeostasis. Am J Respir Crit Care Med 2000; 161:414-419.
47. Crothers K. Chronic obstructive pulmonary disease in patients who have HIV infection. Clin Chest Med 2007; 28:575-587vi.
48. Morris A, Gingo MR, George MP, Lucht L, Kessinger C, Singh V, et al. Cardiopulmonary function in individuals with HIV infection in the antiretroviral therapy era. AIDS 2012; 26:731-740.
49. Gingo MR, Morris A. Pathogenesis of HIV and the lung. Curr HIV/AIDS Rep 2013; 10:42-50.
50. Armah KA, McGinnis K, Baker J, Gibert C, Butt AA, Bryant KJ, et al. HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation. Clin Infect Dis 2012; 55:126-136.
51. Szabo G, Mandrekar P. A recent perspective on alcohol, immunity, and host defense. Alcohol Clin Exp Res 2009; 33:220-232.
52. Yeh MY, Burnham EL, Moss M, Brown LA. Chronic alcoholism alters systemic and pulmonary glutathione redox status. Am J Respir Crit Care Med 2007; 176:270-276.
53. Elliott MK, Sisson JH, Wyatt TA. Effects of cigarette smoke and alcohol on ciliated tracheal epithelium and inflammatory cell recruitment. Am J Respir Cell Mol Biol 2007; 36:452-459.
54. Sisson JH. Alcohol and airways function in health and disease. Alcohol 2007; 41:293-307.
55. Groenewegen KH, Postma DS, Hop WC, Wielders PL, Schlosser NJ, Wouters EF. Increased systemic inflammation is a risk factor for COPD exacerbations. Chest 2008; 133:350-357.
56. Walker JE Jr, Odden AR, Jeyaseelan S, Zhang P, Bagby GJ, Nelson S, et al. Ethanol exposure impairs LPS-induced pulmonary LIX expression: alveolar epithelial cell dysfunction as a consequence of acute intoxication. Alcohol Clin Exp Res 2009; 33:357-365.
57. Zhang P, Bagby GJ, Happel KI, Raasch CE, Nelson S. Alcohol abuse, immunosuppression, and pulmonary infection. Curr Drug Abuse Rev 2008; 1:56-67.
58. Justice AC, Dombrowski E, Conigliaro J, Fultz SL, Gibson D, Madenwald T, et al. Veterans Aging Cohort Study (VACS): Overview and description. Med Care 2006; 44(8 Suppl 2): S13-S24.
59. Fultz SL, Skanderson M, Mole LA, Gandhi N, Bryant K, Crystal S, et al. Development and verification of a 'virtual' cohort using the National VA Health Information System. Med Care 2006; 44:S25-S30.
60. McGinnis KA, Brandt CA, Skanderson M, Justice AC, Shahrir S, Butt AA, et al. Validating smoking data from the Veteran's Affairs Health Factors dataset, an electronic data source. Nicotine Tob Res 2011; 13:1233-1239.
61. Justice AC, Lasky E, McGinnis KA, Skanderson M, Conigliaro J, Fultz SL, et al. Medical disease and alcohol use among veterans with human immunodeficiency infection: a comparison of disease measurement strategies. Med Care 2006; 44:S52-S60.
62. Gingo MR, Balasubramani GK, Rice TB, Kingsley L, Kleerup EC, Detels R, et al. Pulmonary symptoms and diagnoses are associated with HIV in the MACS and WIHS cohorts. BMC Pulm Med 2014; 14:75.
63. Crothers K, Butt AA, Gibert CL, Rodriguez-Barradas MC, Crystal S, Justice AC. Increased COPD among HIV-positive compared to HIV-negative veterans. Chest 2006; 130:1326-1333.
64. Attia EF, Akgun KM, Wongtrakool C, Goetz MB, Rodriguez-Barradas MC, Rimland D, et al. Increased risk of radiographic emphysema in HIV is associated with elevated soluble CD14 and nadir CD4. Chest 2014; 146:1543-1553.
65. Rentsch C, Tate JP, Akgun KM, Crystal S, Wang KH, Ryan Greysen S, et al. Alcohol-related diagnoses and all-cause hos-pitalization among HIV-infected and uninfected patients: a longitudinal analysis of United States veterans from 1997 to 2011. AIDS Behav 2015[Epub ahead of print].
66. Tran HN, Siu S, Iribarren C, Udaltsova N, Klatsky AL. Ethnicity and risk of hospitalization for asthma and chronic obstructive pulmonary disease. Ann Epidemiol 2011; 21:615-622.
67. Lindenauer PK, Pekow P, Gao S, Crawford AS, Gutierrez B, Benjamin EM. Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 2006; 144:894-903.
68. Mularski RA, Asch SM, Shrank WH, Kerr EA, Setodji CM, Adams JL, et al. The quality of obstructive lung disease care for adults in the United States as measured by adherence to recommended processes. Chest 2006; 130:1844-1850.
69. Yip NH, Yuen G, Lazar EJ, Regan BK, Brinson MD, Taylor B, et al. Analysis of hospitalizations for COPD exacerbation: opportunities for improving care. COPD 2010; 7:85-92.